0.89
-9.18%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Stablecoin Development
From its filings with the US Securities and Exchange Commission
Stablecoin Development is based in West Palm Beach, Florida and is incorporated in Delaware. Its shares trade on NYSE under the ticker SDEV. The SEC classifies its business as finance services. In the fiscal year to 31 December 2024, it reported revenue of $9.8m.
We have undergone significant changes to our business and operations as a result of a series of completed transactions summarized below and discussed in further detail under the next section titled “Recent Developments” below. As a result of these transactions, we have significantly reduced our legacy pharmaceutical business operations and have adopted a new strategic direction as a business, shifting to a capital allocation strategy that focuses on acquiring digital assets that provide exposure to economic participation within open digital financial networks.
We were historically focused on the development and sale of scientifically-created and clinically-proven eyecare, wound care, and skin care products. In the past year, we completed a comprehensive realignment of our business. We have adopted a capital allocation strategy focused on acquiring digital assets that provide exposure to economic participation within open digital financial networks.
On January 16, 2026, we completed a private placement of pre-funded warrants to purchase an aggregate of 167,539,227 shares of common stock of the Company, par value $0.01 per share (the “Common Stock”) in exchange for $25 million of cash and an aggregate of approximately $112.4 million in SKY tokens and stablecoins (the “Private Placement”).
Quoted from its 10-K, filed 19 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Listed since
- 26 Oct 2007
- Website
- stabledev.com ↗
- Head office
- 222 LAKEVIEW AVE, SUITE 800, WEST PALM BEACH, FL, 33401
- Incorporated in
- DE
- Classification
- Finance Services
- Filer status
- Non-accelerated filer<br>Smaller reporting company
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Stablecoin Development Corporation holds SKY tokens for protocol-level services like staking and governance.
- The company's focus on SKY deployment supports blockchain network participation.
- Stablecoin Development Corporation has a long history since its 2000 incorporation.
Weaknesses
- The company's name change from NovaBay Pharmaceuticals to Stablecoin Development Corporation in 2026 may confuse investors.
- Stablecoin Development Corporation's business is limited to SKY token activities.
- The company's digital asset focus may face regulatory challenges in the US.
Opportunities
- Stablecoin Development Corporation can expand SKY token usage across new blockchain networks.
- The company may benefit from growing interest in decentralized finance (DeFi) platforms.
- Stablecoin Development Corporation could leverage its 2000 incorporation date for brand trust.
Threats
- Regulatory scrutiny on digital assets could impact Stablecoin Development Corporation's operations.
- The SKY token's value may fluctuate, affecting the company's asset holdings.
- Stablecoin Development Corporation faces competition from other blockchain protocol companies.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.